Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 721-730 of 2932 for cancer

Edit search filters
  1. A Study To Evaluate KIN-2787 In Participants With BRAF And/or NRAS Mutation Positive Solid Tumors

    Jacksonville, FL, Rochester, MN

  2. TheraSphere With And Without Durvalumab And Tremelimumab For HCC

    Jacksonville, FL

  3. A Clinical Study To Assess The Efficacy And Safety Of Alpha DaRT224 For The Treatment Of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

    Rochester, MN

  4. A Randomized Phase III Trial Of Eribulin Compared To Standard Weekly Paclitaxel As First- Or Second-Line Therapy For Locally Recurrent Or Metastatic Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study To Evaluate The Efficacy Of Cemsidomide + Dexamethasone In Participants With Relapsed/Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Phase 1 Study Evaluating The Safety, PK, And Clinical Effects Of PT-112 In Subjects With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Dose Escalation And Confirmation Study Of PT-112 In Advanced Solid Tumors In Combination With Avelumab

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Study Of Safety, Pharmacokinetic And Efficacy Of APG-5918 In Advanced Solid Tumors Or Lymphomas

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Alisertib With Or Without Fulvestrant In Treating Patients With Locally Advanced Or Metastatic, Endocrine-Resistant Breast Cancer

    Rochester, MN

  10. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations

    Rochester, MN

.

Mayo Clinic Footer